Emergent BioSolutions Inc.
SEC 4 · Filed
0002043716-26-000005Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Mar 3, 2026
Grant, award or other acquisition by Perl Jessica
- Security
- Employee Stock Option (Right to buy)
- Shares
-
46,702
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-03-03",
"direction": "A",
"exercise_price": "8.99",
"expiration": "2033-03-02",
"footnotes": {
"F2": "Vests in three equal installments beginning on the day prior to the anniversary date of the grant."
},
"owners": [
{
"cik": "0002043716",
"name": "Perl Jessica",
"roles": [
"officer"
],
"title": "SVP, General Counsel, Corp Sec"
}
],
"ownership": "D",
"post_shares": "142647",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Employee Stock Option (Right to buy)",
"shares": "46702",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "46702"
}Insider transactionsEvent date Mar 5, 2026
Payment of exercise price or tax by delivery of securities by Perl Jessica
- Security
- Common Stock
- Shares
-
6,465
- Price per share
-
8.44
Structured facts
{
"code": "F",
"date": "2026-03-05",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units"
},
"owners": [
{
"cik": "0002043716",
"name": "Perl Jessica",
"roles": [
"officer"
],
"title": "SVP, General Counsel, Corp Sec"
}
],
"ownership": "D",
"post_shares": "61004",
"price": "8.44",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "6465",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}